Updated:
FemTec Health
FemTec Health is a Houston-based company building a digital health and beauty platform through brand acquisitions and telehealth services.
FemTec Health
FemTec Health operates at the intersection of digital health and consumer beauty, building a vertically integrated platform that offers clinical telehealth consultations, personalized skincare formulations, and monthly product subscriptions. The company was founded by Ron Robinson, a former L'Oréal executive with a background in cosmetics chemistry, and Ben Isaacson, the firm's general partner. The wealth origin underlying the company is not publicly disclosed, but the Series A round drew participation from Mirae Asset Capital and a handful of family offices, suggesting private capital backing. The company's strategy centers on acquiring established direct-to-consumer brands and integrating them into its proprietary health-and-beauty ecosystem. Confirmed acquisitions include Beauty by Imagination, a beauty tools brand, and Moonie CBD, a cannabidiol-infused wellness line. FemTec Health also operates its own telehealth service, MyFemTec, which provides virtual consultations for hormonal health, menopause, and skincare. Geographically, the company focuses on the US market, with limited international expansion. FemTec Health's team size and office structure beyond Houston are not publicly specified, nor is any philanthropic or affiliated vehicle known. The most recent operational event of note is the 2021 Series A close; no subsequent funding rounds or major corporate developments have surfaced as of early 2026. A structural differentiator for FemTec Health is its acquisition-led integration model, which is more common in consumer goods conglomerates than in digital health startups. Instead of building a brand from scratch, it purchases existing direct-to-consumer labels and folds them into a unified platform spanning clinical care, product development, and subscription commerce — a model resembling a health-focused version of a roll-up consumer-goods holding company.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Houston
Corporate office
Houston, TX, United States
Sector focus
Frequently asked questions
Who runs investment decisions at FemTec Health?
Investment decisions are led by co-founders Ron Robinson, CEO, and Ben Isaacson, a general partner whose background includes venture and private equity. External investors in the Series A round include elsevea ventures and Mirae Asset Capital, but the firm's internal governance structure for capital allocation is not publicly detailed.
How does FemTec Health source proprietary deal flow?
FemTec Health sources acquisitions through relationships built by its leadership team, which includes former L'Oréal executives with deep industry networks in beauty and wellness. The company publicly states its strategy of acquiring direct-to-consumer brands that can be integrated into its platform, likely making inbound interest from brand founders and investment bankers a primary source.
Is FemTec Health structured as a single family office or does it operate more like a venture firm?
FemTec Health is a private company — not a family office or a venture firm. It operates as a commercial consumer-health company that raised venture capital to fund acquisitions and platform buildout. The investors in its Series A include institutional and family office capital, but the firm itself is a corporation, not an investment vehicle.
Does FemTec Health participate in fund commitments or only direct deals?
FemTec Health makes direct acquisitions of brands and operates its own service lines. It does not invest in external funds or third-party companies as a limited partner. Its capital deployment is entirely through its own balance sheet and fundraising rounds.
What investment stages does FemTec Health typically target?
FemTec Health targets established direct-to-consumer brands that are past the startup phase and ready for integration into a multi-brand platform. This is akin to a growth-stage roll-up, acquiring companies with existing revenue and customer bases rather than seed-stage or early-stage venture investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: